Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade